Tianjin Weijie Pharmaceutical has successfully passed its third US FDA inspection. The inspection took place from 8thto 12thJanuary. The entire quality systems for API manufacturing related to production, equipment, manufacturing facilities, materials and quality control were inspected. The quality systems were approved and the inspection was classified as VAI (Voluntary Action Indicated). This is excellent news for Tianjin Weijie Pharmaceutical and its customers. It is another step forward in our continuous efforts for business excellence.